Publication | Open Access
Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis
10
Citations
0
References
2019
Year
The studies identify the acid sphingomyelinase as a novel therapeutic target for treating MS patients.